Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 12, 2007 - Issue 1
Submit an article Journal homepage
117
Views
10
CrossRef citations to date
0
Altmetric
Review

Emerging drugs in multiple myeloma

Irene M Ghobrial Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. [email protected]; Harvard Medical School, Boston, MA 02115, USA
,
Xavier Leleu Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
,
Evdoxia Hatjiharissi Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
,
Teru Hideshima Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
,
Constantine Mitsiades Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
,
Robert Schlossman Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
,
Kenneth C Anderson Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
&
Paul Richardson Harvard Medical School, Boston, MA 02115, USA; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
 show all
Pages 155-163 | Published online: 14 Mar 2007

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thiruma V Arumugam, Pradeep K Selvaraj, Trent M Woodruff & Mark P Mattson. (2008) Targeting ischemic brain injury with intravenous immunoglobulin. Expert Opinion on Therapeutic Targets 12:1, pages 19-29.
Read now
Pellegrino Musto & Fiorella D'Auria. (2007) Melphalan: old and new uses of a still master drug for multiple myeloma. Expert Opinion on Investigational Drugs 16:9, pages 1467-1487.
Read now

Articles from other publishers (8)

Feda Azab, Shireen Vali, Joseph Abraham, Nicholas Potter, Barbara Muz, Pilar de la Puente, Mark Fiala, Jacob Paasch, Zeba Sultana, Anuj Tyagi, Taher Abbasi, Ravi Vij & Abdel Kareem Azab. (2014) PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance. British Journal of Haematology 165:1, pages 89-101.
Crossref
J Glauer, N Pletz, M Schön, P Schneider, N Liu, K Ziegelbauer, S Emmert, G G Wulf & M P Schön. (2013) A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo. Blood Cancer Journal 3:9, pages e141-e141.
Crossref
Wonseok KangJin Seok KimSang Ho ChoSung Kyu KimJoon ChangMoo Suk Park. (2010) Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient. Yonsei Medical Journal 51:3, pages 448.
Crossref
Abdel Kareem Azab, Judith M. Runnels, Costas Pitsillides, Anne-Sophie MoreauFeda AzabXavier LeleuXiaoying JiaRenee Wright, Beatriz Ospina, Alicia L. Carlson, Clemens Alt, Nicholas BurwickAldo M. RoccaroHai T. NgoMena FaragMolly R. MelhemAntonio SaccoNikhil C. MunshiTeru HideshimaBarrett J. RollinsKenneth C. AndersonAndrew L. Kung, Charles P. Lin & Irene M. Ghobrial. (2009) CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 113:18, pages 4341-4351.
Crossref
Carl E. Freter & Michael C. Perry. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 449 483 .
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref
Melissa Alsina & Paul Richardson. 2007. Multiple Myeloma: Translational and Emerging Therapies. Multiple Myeloma: Translational and Emerging Therapies 169 196 .
Antonio Palumbo & Mario Boccadoro. (2007) A new standard of care for elderly patients with myeloma. The Lancet 370:9594, pages 1191-1192.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.